BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 20227854)

  • 1. In vitro activity of tigecycline in Plasmodium falciparum culture-adapted strains and clinical isolates from Gabon.
    Held J; Zanger P; Issifou S; Kremsner PG; Mordmüller B
    Int J Antimicrob Agents; 2010 Jun; 35(6):587-9. PubMed ID: 20227854
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comprehensive study of proteasome inhibitors against Plasmodium falciparum laboratory strains and field isolates from Gabon.
    Kreidenweiss A; Kremsner PG; Mordmüller B
    Malar J; 2008 Sep; 7():187. PubMed ID: 18816382
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro antimalarial activity of tigecycline against Plasmodium falciparum culture-adapted reference strains and clinical isolates from the Brazilian Amazon.
    Ribatski-Silva D; Bassi CL; Martin TO; Alves-Junior E; Gomes LT; Fontes CJ
    Rev Soc Bras Med Trop; 2014; 47(1):110-2. PubMed ID: 24553805
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro activity of iron-binding compounds against Senegalese isolates of Plasmodium falciparum.
    Pradines B; Tall A; Ramiandrasoa F; Spiegel A; Sokhna C; Fusai T; Mosnier J; Daries W; Trape JF; Kunesch G; Parzy D; Rogier C
    J Antimicrob Chemother; 2006 Jun; 57(6):1093-9. PubMed ID: 16595639
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro sensitivity of Plasmodium falciparum to conventional and novel antimalarial drugs in Papua New Guinea.
    Wong RP; Lautu D; Tavul L; Hackett SL; Siba P; Karunajeewa HA; Ilett KF; Mueller I; Davis TM
    Trop Med Int Health; 2010 Mar; 15(3):342-9. PubMed ID: 20070627
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Declining chloroquine resistance of Plasmodium falciparum in Lambaréné, Gabon from 1992 to 1998.
    Schwenke A; Brandts C; Philipps J; Winkler S; Wernsdorfer WH; Kremsner PG
    Wien Klin Wochenschr; 2001 Jan; 113(1-2):63-4. PubMed ID: 11233471
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antimalarial activity of tigecycline, a novel glycylcycline antibiotic.
    Starzengruber P; Thriemer K; Haque R; Khan WA; Fuehrer HP; Siedl A; Hofecker V; Ley B; Wernsdorfer WH; Noedl H
    Antimicrob Agents Chemother; 2009 Sep; 53(9):4040-2. PubMed ID: 19596882
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Delayed parasite elimination in human infections treated with clindamycin parallels 'delayed death' of Plasmodium falciparum in vitro.
    Burkhardt D; Wiesner J; Stoesser N; Ramharter M; Uhlemann AC; Issifou S; Jomaa H; Krishna S; Kremsner PG; Borrmann S
    Int J Parasitol; 2007 Jun; 37(7):777-85. PubMed ID: 17280676
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [In vitro sensitivity of Plasmodium falciparum isolates from Gabon to chloroquine and cycloguanil].
    Pradines B; Mabika Mamfoumbi M; Keundjian A; Lebeau C; Fusai T; Owono Medang M; Rogier C; Parzy D; Kombila M
    Bull Soc Pathol Exot; 1999 May; 92(2):91-4. PubMed ID: 10399596
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro susceptibility to a new antimalarial organometallic analogue, ferroquine, of Plasmodium falciparum isolates from the Haut-Ogooué region of Gabon.
    Atteke C; Ndong JM; Aubouy A; Maciejewski L; Brocard J; Lébibi J; Deloron P
    J Antimicrob Chemother; 2003 Apr; 51(4):1021-4. PubMed ID: 12654770
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Madagascan isolates of Plasmodium falciparum showing low sensitivity to artemether in vitro.
    Randrianarivelojosia M; Raharimalala LA; Randrianasolo L; Ratsimbasoa A; Rason MA; Ariey F; Jambou R
    Ann Trop Med Parasitol; 2001 Apr; 95(3):237-43. PubMed ID: 11339883
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro activity of new artemisinin derivatives against Plasmodium falciparum clinical isolates from Gabon.
    Held J; Soomro SA; Kremsner PG; Jansen FH; Mordmüller B
    Int J Antimicrob Agents; 2011 May; 37(5):485-8. PubMed ID: 21392942
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro susceptibility of P. falciparum populations from Colombia and Tanzania to a new synthetic peroxide (OZ277).
    Osorio L; Murillo C; Aponte S; Mayagaya V; Scheurer C; Brun R; Matile H; Wittlin S
    Am J Trop Med Hyg; 2007 Jun; 76(6):1024-6. PubMed ID: 17556605
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro activity of mirincamycin (U24729A) against Plasmodium falciparum isolates from Gabon.
    Held J; Westerman R; Kremsner PG; Mordmüller B
    Antimicrob Agents Chemother; 2010 Jan; 54(1):540-2. PubMed ID: 19841147
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular epidemiology of malaria in Cameroon. XVII. Baseline monitoring of atovaquone-resistant Plasmodium falciparum by in vitro drug assays and cytochrome b gene sequence analysis.
    Basco LK
    Am J Trop Med Hyg; 2003 Aug; 69(2):179-83. PubMed ID: 14506774
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fosmidomycin-clindamycin for the treatment of Plasmodium falciparum malaria.
    Borrmann S; Issifou S; Esser G; Adegnika AA; Ramharter M; Matsiegui PB; Oyakhirome S; Mawili-Mboumba DP; Missinou MA; Kun JF; Jomaa H; Kremsner PG
    J Infect Dis; 2004 Nov; 190(9):1534-40. PubMed ID: 15478056
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of a SYBR green I-based assay with a histidine-rich protein II enzyme-linked immunosorbent assay for in vitro antimalarial drug efficacy testing and application to clinical isolates.
    Bacon DJ; Latour C; Lucas C; Colina O; Ringwald P; Picot S
    Antimicrob Agents Chemother; 2007 Apr; 51(4):1172-8. PubMed ID: 17220424
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular epidemiology of malaria in Cameroon. XV. Experimental studies on serum substitutes and supplements and alternative culture media for in vitro drug sensitivity assays using fresh isolates of Plasmodium falciparum.
    Basco LK
    Am J Trop Med Hyg; 2003 Aug; 69(2):168-73. PubMed ID: 14506772
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessment of the drug susceptibility of Plasmodium falciparum clinical isolates from africa by using a Plasmodium lactate dehydrogenase immunodetection assay and an inhibitory maximum effect model for precise measurement of the 50-percent inhibitory concentration.
    Kaddouri H; Nakache S; Houzé S; Mentré F; Le Bras J
    Antimicrob Agents Chemother; 2006 Oct; 50(10):3343-9. PubMed ID: 17005815
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro sensitivity of Plasmodium falciparum to amodiaquine compared with other major antimalarials in Madagascar.
    Randrianarivelojosia M; Harisoa JL; Rabarijaona LP; Raharimalala LA; Ranaivo L; Pietra V; Duchemin JB; Rakotomanana F; Robert V; Mauclere P; Ariey F
    Parassitologia; 2002 Dec; 44(3-4):141-7. PubMed ID: 12701375
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.